$7.22 +0.61 (%) Ariad Pharmaceuticals Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Mid-Afternoon Market Update: Oxford Industries Drops On Downbeat Results; Office Depot Shares Spike Higher

    Benzinga | Dec. 11, 2014 | 15:59PM EST
  2. Mid-Day Market Update: Dow Jumps Over 200 Points; Staples Shares Surge On Confirmation Of Stake By Starboard Value

    Benzinga | Dec. 11, 2014 | 12:40PM EST
  3. Mid-Morning Market Update: Markets Surge; Lululemon Profit Beats Expectations

    Benzinga | Dec. 11, 2014 | 10:57AM EST
  4. Morning Market Losers

    Benzinga | Dec. 11, 2014 | 09:57AM EST
  5. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 11, 2014 | 08:28AM EST
  6. ARIAD Reports Follow-up Data from Phase 1, PACE Trials of Ponatinib for T315I Mutation

    Benzinga | Dec. 9, 2014 | 07:37AM EST
  7. ARIAD Reports Long-term Safety, Efficacy Data of Ponatinib from Phase 2 Pace Trial: 83% of CP-CML Patients Achieved Response

    Benzinga | Dec. 8, 2014 | 07:36AM EST
  8. Morning Market Movers

    Benzinga | Nov. 24, 2014 | 09:46AM EST
  9. Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals

    Benzinga | Nov. 6, 2014 | 09:58AM EST
  10. Earnings Scheduled For November 5, 2014

    Benzinga | Nov. 5, 2014 | 05:05AM EST
  11. ARIAD Announces Recommendation For Iclusig By The Pharmacovigilance Risk Assessment Committee Of The European Medicines Agency

    Benzinga | Oct. 10, 2014 | 07:46AM EST
  12. Wayfair rises, Westport Innovations cuts 2014 forecast

    FoxBusiness | Oct. 6, 2014 | 08:30AM EST
  13. Markets Mixed; Constellation Brands Posts Downbeat Profit

    Benzinga | Oct. 2, 2014 | 10:38AM EST
  14. Morning Market Movers

    Benzinga | Oct. 2, 2014 | 09:44AM EST
  15. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 2, 2014 | 08:38AM EST
  16. ARIAD Offers Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer

    Benzinga | Sep. 29, 2014 | 07:36AM EST
  17. GNC, Southern Copper And Others Insiders Have Been Buying

    Benzinga | Aug. 25, 2014 | 13:34PM EST
  18. ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel

    Benzinga | Aug. 5, 2014 | 07:41AM EST
  19. Morning Market Movers

    Benzinga | Jul. 24, 2014 | 09:44AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 24, 2014 | 08:08AM EST
  21. Benzinga's M&A Chatter for Wednesday July 23, 2014

    Benzinga | Jul. 23, 2014 | 18:48PM EST
  22. ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure in Europe

    Benzinga | Jul. 14, 2014 | 07:36AM EST
  23. 3 Biotech Stocks Backed By Big Money

    Benzinga | Jun. 16, 2014 | 14:27PM EST
  24. Morning Market Losers

    Benzinga | Jun. 12, 2014 | 09:43AM EST
  25. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 12, 2014 | 08:08AM EST
  26. Earnings Scheduled For May 7, 2014

    Benzinga | May. 7, 2014 | 05:15AM EST
  27. Morning Market Movers

    Benzinga | May. 5, 2014 | 09:45AM EST
  28. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 5, 2014 | 08:09AM EST
  29. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains

    Benzinga | Mar. 28, 2014 | 16:27PM EST
  30. Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte Shares Drop

    Benzinga | Mar. 28, 2014 | 12:23PM EST
  31. Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Smaller-Than-Expected Loss

    Benzinga | Mar. 28, 2014 | 10:22AM EST
  32. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 28, 2014 | 08:08AM EST
  33. Morning Market Movers

    Benzinga | Mar. 25, 2014 | 09:39AM EST
  34. Top Trending Tickers On StockTwits For March 14

    Benzinga | Mar. 14, 2014 | 09:40AM EST
  35. Benzinga's Top Downgrades

    Benzinga | Feb. 26, 2014 | 08:23AM EST
  36. Market Wrap For February 25: Markets End The Day Relatively Flat

    Benzinga | Feb. 25, 2014 | 16:38PM EST
  37. Top Trending Tickers On StockTwits For February 25

    Benzinga | Feb. 25, 2014 | 11:12AM EST
  38. Earnings Scheduled For February 25, 2014

    Benzinga | Feb. 25, 2014 | 04:28AM EST
  39. You Can No Longer Ignore Biotech

    GuruFocus | Feb. 7, 2014 | 17:32PM EST
  40. Credit Suisse Reports Ariad's Iclusig is 'Essential Drug'

    Benzinga | Feb. 7, 2014 | 14:46PM EST
  41. Tug Of War In Ariad Pharmaceuticals

    Benzinga | Jan. 28, 2014 | 14:36PM EST
  42. Benzinga's M&A Chatter for Monday January 27, 2014

    Benzinga | Jan. 27, 2014 | 17:21PM EST
  43. Top Trending Tickers On StockTwits For January 27

    Benzinga | Jan. 27, 2014 | 09:20AM EST
  44. Market Wrap For January 24: Fear Is Back In The Markets

    Benzinga | Jan. 24, 2014 | 16:30PM EST
  45. Ariad Shares Continue to Surge Amidst Buyout Rumors

    Benzinga | Jan. 24, 2014 | 16:06PM EST
  46. Ariad Pharnaceuticals Continues To Rally

    Benzinga | Jan. 24, 2014 | 15:32PM EST
  47. Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft Provides on of the Few Havens of Strength

    Benzinga | Jan. 24, 2014 | 15:32PM EST
  48. Top Trending Tickers On StockTwits For January 23

    Benzinga | Jan. 23, 2014 | 11:15AM EST
  49. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 23, 2014 | 08:09AM EST
  50. Benzinga's M&A Chatter for Wednesday January 22, 2014

    Benzinga | Jan. 22, 2014 | 18:31PM EST
Trading Center